"To be a patient here and to see what it means for
my family to get this kind of quality care
right here is so significant,"
Dusty- In remission after battling Stage IV B-cell lymphoma,
beloved pastor, Dr. Amy Thompson's other half
He is especially grateful for the team at Joe Arrington Cancer
Center and the ability to receive advanced cancer care close to
home.
Dusty's journey is a powerful reminder that exceptional care is
not just about treatment — it is about compassion, expertise,
and walking alongside patients and families in their most
difficult moments.
At Covenant Health, we are proud to stand beside Dusty and will
continue supporting him every step of the way.
To our community, Dusty Thompson is a beloved pastor and
spiritual leader. To our Covenant Health family, he is Dr. Amy
Thompson's other half. To the caregivers at Joe Arrington
Cancer Center, he is a courageous patient.
In June, Dusty was diagnosed with Stage IV B-cell lymphoma.
What began as persistent back pain, fatigue, and night sweats
initially seemed like a virus. But after lab work and an
admission through Covenant Medical Center's Emergency
Department, imaging revealed lesions throughout his spine. A
biopsy confirmed the diagnosis, and a follow-up PET scan
showed the cancer had spread to bones across his body.
Treatment began immediately. Dusty completed a week of
inpatient chemotherapy before transitioning to outpatient
care at Covenant Health's Joe Arrington Cancer Center. Since
then, he has completed six rounds of chemotherapy — facing
each step with resilience and faith. Though he has spent years
connected to healthcare through Amy's leadership at Covenant
Health, becoming a patient himself offered a deeply personal
perspective.
Reflecting on those first days after diagnosis, Dusty shared,
"It's kind of like you think it might be… really, really hard." Yet
even in the uncertainty, he continues to fight daily, grounded
in his faith and supported by his family.
Dusty Thompson- Faith, Family, and the
Fight Forward.
COVENANT HEALTH 2025 ANNUAL REPORT
1
